Akoya Biosciences, Inc. (AKYA)
Latest AKYA Insider Trades
Robert G. Shepler - DirectorOther16,860 sh- Robert G. Shepler - DirectorOther30,549 sh
- Robert G. Shepler - Director
About Akoya Biosciences, Inc. (AKYA)
Akoya Biosciences, Inc. is an SEC registrant, filing under CIK 0001711933, classified as laboratory analytical instruments. It is grouped with Health Care companies on this site.
90-Day SEC Filing Activity
No Form 4 activity for AKYA in the last 90 days.
AKYA Insider Transactions (Form 4)
7017 Form 4 filings on record, the earliest from Oct 4, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Robert G. Shepler - Director | Other | Stock Option (Right to Buy) |
AKYA Insider Trading - FAQ
What is the latest insider trade for AKYA?
Akoya Biosciences, Inc. (AKYA) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-07-08. The full record for AKYA runs to 17 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying AKYA stock?
No insider purchases of AKYA were filed in the last 90 days.
How many insiders are selling AKYA stock?
No insider sales of AKYA were filed in the last 90 days.
Where can I see AKYA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks AKYA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow AKYA insider buys?
Create a free InsiderAlpha account and press Watch on this page to add AKYA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Robert G. Shepler view on EDGAR
- - Goldman Myla Lai view on EDGAR
- - Thomas P. Schnettler view on EDGAR
- - Thomas A. Raffin view on EDGAR
- - Scott Mendel view on EDGAR
- - Matthew Winkler view on EDGAR
- - Brian McKelligon view on EDGAR
- - Jennifer Kamocsay view on EDGAR
- - Niro Ph.D Ramachandran view on EDGAR
- - John Frederick Ek view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where AKYA's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track AKYA insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
